FDA Investigator Alan E Mehl
Alan E Mehl has conducted inspections on 15 sites in 1 countries as of 28 Aug 2000. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
15
Last Inspection Date:
28 Aug 2000
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Alan E Mehl:
Alan L Truong,
Ashley A Mutawakkil,
Barbara I Rogolsky,
Brenda C Hamilton,
Brittany D Terhar,
Bryan S Roddy,
Carl J Montgomery,
Chilton L Ng,
Chris A Sack,
Cody J Alley,
Courtney R Bratina,
Cynthia M Goudeau,
Danial S Hutchison,
Daniel R Hurt,
Darrah,
David J Eide,
Diana K Krepel,
Diane L Raccasi,
Dina K West,
Dr. Sriram Subramaniam, PhD,
Eric M Mueller, PharmD,
Evelyne L Weaver,
Farhana Khan,
Gretchen Lf Trendel,
Gwyn G Dickinson,
Heath W Cartwright,
Ingrid Y Johnson,
J Michael Cannon, PhD,
James D Planchon,
James P Mcreavey,
Janete A Oliveira,
Jessica E Hensley,
Jill J Tillman,
Joseph R Lambert,
Julie N Vosilus,
Karen M Montgomery (KMM),
Kellia N Hicks,
LCDR Ismael Olvera, IV,
Linda K Cline,
Linda R Kuchenthal,
Linhart,
Lisa L Flores,
Lisa L Gilliam,
Marcus F Yambot,
Marion D Wimberly, Jr,
Martin K Yau, PhD,
Matthew R Sleeter,
Megan T Ziegler,
Merril E Racke,
Merril Racke, PhD,
Michael A Feingold,
Michael C Zubelewicz,
Michael S Smoker,
Michele L Obert,
Michele Perry Williams,
Minerva Rogers,
Monique M Brooks,
Neal L Adams,
Patrick L Wisor,
Richard D Coleman,
Rita K Kabaso,
Robin K Reel,
Shannan B Beisser,
Shirley J Berryman,
Shwnji Susie Lee,
Steven D Kehoe,
Susanna E Ford,
Susie H Lee,
Suzanna E Ford,
Tamara J Umscheid,
Tara L Breckenridge,
Tara L Greene,
Tara L King,
Thomas J Arista,
Torrey M Ward,
Veronica Fuentes, MS,
Victoria A Wagoner,
Vinh T Phan,
Warren J Lopicka,
Wayne D Mcgrath,
Zachary A Bogorad
Alan E Mehl's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | EIR | Pharmgate Inc. - EIR, 2000-01-31 |
March, 2000 | EIR | Sanofi - Aventis US LLC - EIR, 2000-03-08 |
June, 2000 | EIR | Pharmgate Inc. - EIR, 2000-06-14 |
May, 2000 | EIR | Sanofi - Aventis US LLC - EIR, 2000-05-31 |
April, 2000 | EIR | York Pharmaceuticals Inc - EIR, 2000-04-07 |
May, 2000 | FDA 483 | Sanofi - Aventis US LLC - Form 483, 2000-05-31 |
April, 2000 | FDA 483 | York Pharmaceuticals, Inc. - Form 483, 2000-04-07 |
August, 2000 | EIR | TriRx Shawnee LLC - EIR, 2000-08-30 |
July, 2000 | FDA 483 | EPM Packaging Inc - Form 483, 2000-07-27 |
May, 2000 | EIR | Catalent CTS, LLC - EIR, 2000-05-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more